EELEM Biotech — Seed (estimated) · approximately €1.2M
ELEM Biotech, a spin-off of the Barcelona Supercomputing Center, raised about €1.2M through Capital Cell crowdfunding at a €7.5M pre-money valuation to bring V.HEART to market. V.HEART runs cardiac clinical trials on virtual human populations. Namarel Ventures and Roger Assaker are among the family-office and angel backers.
Lead not disclosed
RoundSeed (estimated)
Announced17 Dec 2021
CityBarcelona
SectorHealthtech & Bio · Healthtech / In-silico clinical trials
Source
C
C
